For the Inventor, By the Inventor

Enter assignee name

Nijmegen, Netherlands

Syntarga Bv

USPTO Granted Patents = 10

CIPO Patents = 17

EPO Patents = 7

Forward Citations = 234

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Patrick Henry Beusker (10 out of 14 patents)

Franciscus Marinus Hendrikus De Groot (10 out of 11 patents)

Johannes Albertus Frederikus Joosten (7 out of 8 patents)

4. Henri Johannes Spijker (7 out of 9 patents)

5. Rudy Gerardus Elisabeth Coumans (4 out of 16 patents)

6. Ronald Christiaan Elgersma (4 out of 6 patents)

7. Wiro Michael Petrus Bernardus Menge (3 out of 4 patents)

8. Tijl Huijbregts (2 out of 4 patents)

9. Johannes Wilhelm Scheeren (2 out of 2 patents)

10. Lutz F Tietze (1 out of 9 patents)

11. Felix Major (1 out of 2 patents)

12. Wiro Michaël Petrus Bernardus Menge (1 out of 1 patent)

13. Dick De Vos (1 out of 12 patents)

14. Leonardus Wilhelmus Adriaan Van Berkom (1 out of 1 patent)

15. Guuske Frederike Busscher (1 out of 1 patent)

10 patents: Sort by Forward Citations

1. 11052155 - Conjugates of CC-1065 analogs and bifunctional linkers (2021-07-06),

2. 9901567 - Substituted CC-1065 analogs and their conjugates (2018-02-27),

3. 9815784 - CC-1065 analogs and their conjugates (2017-11-14),

4. 9629924 - Conjugates of CC-1065 analogs and bifunctional linkers (2017-04-25),

5. 8940784 - Water-soluble CC-1065 analogs and their conjugates (2015-01-27),

6. 8889868 - CC-1065 analogs and their conjugates (2014-11-18),

7. 8680293 - Substituted CC-1065 analogs and their conjugates (2014-03-25),

8. 8158590 - Triazole-containing releasable linkers, conjugates thereof, and methods of preparation (2012-04-17),

9. 7705045 - Prodrugs built as multiple self-elimination-release spacers (2010-04-27),

10. 7223837 - Elongated and multiple spacers in activatible prodrugs (2007-05-29),

Syntarga Bv is a leading biotechnology company specializing in the development of novel drug therapies for rare and orphan diseases. With a strong focus on innovation and research, Syntarga Bv aims to provide patients with new treatment options that are safe, effective, and affordable. The company's pipeline includes promising candidates for a range of conditions, including genetic disorders, autoimmune diseases, and cancer. Syntarga Bv is committed to making a meaningful impact on healthcare and improving the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

10 Patents

#7 in Nijmegen

#608 in Netherlands

#54,271 in the World

Nijmegen, Netherlands

Syntarga Bv

Forward Citations = 234

31 inventors:

Patrick Henry Beusker (10 out of 14 patents)

Franciscus Marinus Hendrikus De Groot (10 out of 11 patents)

Johannes Albertus Frederikus Joosten (7 out of 8 patents)

4. Henri Johannes Spijker (7 out of 9 patents)

5. Rudy Gerardus Elisabeth Coumans (4 out of 16 patents)

Please report any incorrect information to support@idiyas.com

Loading…